Evidence map›Paper›PMID 28587382›Full record

ArticleExperimental and therapeutic medicine2017

Effect of VBC-1814/7J, a poly-phytocompound, on a non-infectious model of pharyngitis.

Junji Uemura, Ravinder Nagpal, Nicola Zerbinati, Birbal Singh, Massimiliano Marcellino, Dheeraj Mohania, Francesco Marotta, Fang He, Antonio Ayala, Yasuhiro Kasugai and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Lysozyme in the treatment of non-infectious sore throat.Bosnian journal of basic medical sciences · 2020
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 5 countries.

Junji UemuraSuheiro Chem-Tech Center, Niigata 950-1447, Japan.
Ravinder NagpalDivision of Laboratories for Probiotic Research, Juntendo University Graduate School of Medicine, Tokyo 162-0803, Japan.
Nicola ZerbinatiCMP-Medical Center and Laboratories, I-27100 Pavia, Italy.
Birbal SinghIndian Veterinary Research Institute, Regional Station, Palampur, Himachal Pradesh 176061, India.
Massimiliano MarcellinoReGenera Research Group for Aging Intervention, I-20154 Milan, Italy.
Dheeraj MohaniaAnimal Biochemistry Division, National Dairy Research Institute, Karnal, Haryana 121001, India.
Francesco MarottaReGenera Research Group for Aging Intervention, I-20154 Milan, Italy.
Fang HeDepartment of Nutrition and Food Hygiene, West China School of Public Health, Sichuan University, Chengdu, Sichuan 610000, P.R. China.
Antonio AyalaDepartment of Biochemistry and Molecular Biology, Seville University, I-41000 Seville, Spain.
Yasuhiro KasugaiSuheiro Chem-Tech Center, Niigata 950-1447, Japan.
Roberto CatanzaroDepartment of Internal Medicine, University of Catania, 95121 Catania, Italy.
Indian Veterinary Research Institute · INJuntendo University · JPNational Dairy Research Institute · INSichuan University · CNUniversidad de Sevilla · ESUniversity of Catania · ITUniversity of Pavia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pharyngitis presents as an inflammation of the oropharynx, and clinical examination often shows evidence of nasopharyngitis. In numerous cases the condition occurs as a self-limiting illness of non-infectious aetiology, whose clinical management remains a matter for debate given the inappropriateness of antibiotics, the reported worsening following steroid use and the recent discouragement of the use of Chinese herbal medicine. The aim of the present study was thus to test VBC-1814/7J, a poly-phytocompound with known anti-inflammatory and immune-response enhancing properties, in an experimental model of non-infectious pharyngitis. Experimental non-infectious pharyngitis was induced by applying a pyridine solution to the surface of the pharyngeal mucosa in rats that were either normally fed (group A) or fed VBC-1814/7J three days prior to and three days subsequent to the induction of pharyngitis (group B). Healthy rats treated with topical saline were used as a control (group C). At time-points of 0, one hour, one day and three days sacrifices were carried out and microscopic examination, Evans blue (EB) dye extravasation and tissue concentrations of tumour necrosis factor (TNF)-α, interleukin (IL)-6 and mRNA of α- and β-defensins were studied. As compared with group C, group A showed significant microscopic damage, EB extravasation, and increases in the levels of TNF-α and IL-6, as well as in the mRNA of three defensins (P<0.001) on the third day of observation. VBC-1814/7J significantly mitigated these microscopic and inflammatory markers while allowing a prompter and wider defensin reaction (P<0.05 vs. group A). These data suggest that VBC-1814/7J, as demonstrated in earlier studies, has the potential to address non-infectious pharyngitis in clinical practice.

Indexed as

non-infectious model of pharyngitisphytocompoundβ-defensins

Identifiers

PMID28587382
PMCPMC5450604
OpenAlexW2605882822

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.